Where does Gradalis, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Gradalis, Inc. ranks #26,400 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Gradalis, Inc. hold?

Gradalis, Inc. holds 10 US utility patents granted between 2015 and 2022, spanning 9 technology areas.

What is Gradalis, Inc.'s Innovation Score?

Gradalis, Inc. has an Innovation Score of 35.6 out of 100 (top 49% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Gradalis, Inc.'s patent grant rate increasing or decreasing?

Gradalis, Inc.'s recent grant velocity is -89% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Gradalis, Inc.'s patents?

Gradalis, Inc.'s patents average 16.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Gradalis, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Gradalis, Inc.

Q: What technology areas does Gradalis, Inc. focus on?

Gradalis, Inc.'s top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 10 patents. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 9 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Gradalis ranks #26,400 of 50,000 tracked US assignees by granted-patent volume, with 10 patents across 9 technology areas.

#26,400
of 50,000 US assignees by volume: Top 49%
by Innovation Score (35.6/100): 16.8
avg claims per patent: -89%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26400 · US Corporation #26,400 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #26,400/50,000
PHOTO-FINISH GOLIATHTECH
CPC-NARROW C12N · 9 areas
INNOV-THIN 35.6/100
CLAIMS-RICH 16.8 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -89% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Goliathtech Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Gradalis · this assignee

36
3D Lighting Innovati… · lowest

7

What this shows Gradalis's Innovation Score is 35.6/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Gradalis's grants concentrate

Gradalis, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2018. By volume, Gradalis sits between Goliathtech Inc. and Greenfield World Trade, Inc..

Gradalis's three-year grant acceleration

Gradalis, Inc. shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Goliathtech

10
Government OF THE…

10
Gowell Internatio…

10
Grace TECH

10
Graff Diamonds

10
Gramercy Extremit…

10
Grayhill

10
Greenfield World…

10
Gradalis ◀

10

What this shows Gradalis holds 10 patents at rank #26,371, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Gradalis

By rank, the assignees closest to #26,371 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Gradalis's primary technology class.

Gradalis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 49% higher than 51% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Gradalis, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	30.0%
2016	2	20.0%
2017	2	20.0%
2018	1	10.0%
2019	1	10.0%
2022	1	10.0%

Which technologies does Gradalis, Inc. patent most?

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 10

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 9

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 9

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 3

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3

C07K - PEPTIDES 3

C07H - SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 1

B01D - SEPARATION 1

Top 9 of 9 technology areas

Where it ranks

Overall rank by patents

#26,400

of 50,000 tracked assignees

Innovation Score

35.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.